TNFRSF10B and breast cancer: Different researchers have also reported that combination treatment with agonistic death receptor 5 mAbs and chemotherapeutic drugs exert a synergistic apoptotic effect in some tumor cell lines, such as lymphoma [12]–[14], breast cancer [15], colorectal cancer [16], and malignant mesothelioma [11].